| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |